IGM Biosciences, Inc. - COM (IGMS)

Historical Portfolio Holders from Q3 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
22.3 M
Holdings value Q1 2024
$215 M
Value change Q1 2024
+$8.72 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
65
Number of buys Q1 2024
35
Number of sells Q1 2024
-28
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
449585108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 22.3 M $215 M +$8.72 M $9.65 65
2023 Q4 21.8 M $181 M -$5.23 M $8.31 69
2023 Q3 22.3 M $186 M +$4.17 M $8.35 75
2023 Q2 21.8 M $201 M +$35.2 M $9.23 75
2023 Q1 17.7 M $244 M -$3.03 M $13.74 73
2022 Q4 18 M $306 M +$821 K $17.01 76
2022 Q3 16.8 M $382 M -$8.18 M $22.74 84
2022 Q2 17.5 M $315 M -$21.9 M $18.03 87
2022 Q1 17.4 M $465 M +$11.2 M $26.73 89
2021 Q4 16.9 M $496 M +$6.4 M $29.33 80
2021 Q3 16.9 M $1.11 B +$20 M $65.76 103
2021 Q2 16.3 M $1.36 B -$126 M $83.20 104
2021 Q1 18 M $1.38 B +$66.6 M $76.69 108
2020 Q4 16 M $1.41 B +$177 M $88.29 106
2020 Q3 14.5 M $1.07 B +$48.4 M $73.81 91
2020 Q2 13.9 M $1.01 B +$45.6 M $73.00 78
2020 Q1 13.3 M $742 M +$66.5 M $56.15 59
2019 Q4 12.2 M $463 M +$92.4 M $38.16 50
2019 Q3 10 M $178 M +$178 M $17.75 33